Document is current
Any future updates will be listed below
-
Authors
van der Geest, Daphne https://orcid.org/0000-0002-0131-4672
van Vliet, Alex
Peeper, Daniel S https://orcid.org/0000-0003-1293-3177
Haanen, John B A G https://orcid.org/0000-0001-5884-7704
Smit, Egbert F https://orcid.org/0000-0002-7329-6995
Theelen, Willemijn S M E
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03546361 at ClinicalTrials.govDocuments that mention this clinical trial
Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better?
https://doi.org/10.1136/jitc-2025-013110
606 Phase I trial of in situ vaccination with autologous <i>CCL21</i> gene-modified dendritic cells (CCL21-DC) combined with pembrolizumab for metastatic NSCLC
https://doi.org/10.1136/jitc-2024-sitc2024.0606
- License Information
